GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:FNCH

Finch Therapeutics Group, Inc. Stock Insider Trading

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$2.24
-0.120 (-5.08%)
At Close: Apr 19, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Mar 28, 2024 Sell 1 600 Smisek Jeffery A Common Stock
Mar 28, 2024 Sell 6 642 Smisek Jeffery A Common Stock
Nov 22, 2023 Sell 1 470 Smisek Jeffery A Common Stock
Jun 09, 2023 Buy 962 899 Blischak Matthew P. Stock Option (right to buy)
Jun 09, 2023 Buy 5 010 Graf Susan E Common Stock
Jun 08, 2023 Buy 962 899 Blischak Matthew P. Stock Option (right to buy)
Jun 08, 2023 Buy 10 000 Lange Christian H. Stock Option (right to buy)
Jun 08, 2023 Buy 10 000 Smisek Jeffery A Stock Option (right to buy)
Jun 08, 2023 Buy 10 000 Haft Nicholas Stock Option (right to buy)
Jun 08, 2023 Buy 10 000 Ferrante Domenic J Stock Option (right to buy)
Jun 08, 2023 Buy 10 000 Graf Susan E Stock Option (right to buy)
Jun 08, 2023 Buy 10 000 Shumway Chris Stock Option (right to buy)
May 16, 2023 Buy 0 Blischak Matthew P.
May 16, 2023 Buy 0 Thibault Lance E
Feb 21, 2023 Sell 4 619 Blaustein Marc Common Stock
Oct 21, 2022 Sell 3 636 Blaustein Marc Common Stock
Oct 21, 2022 Sell 3 636 Vittiglio Joseph Common Stock
Jun 13, 2022 Buy 44 843 Shumway Chris Stock Option (right to buy)
Jun 13, 2022 Buy 44 843 Lange Christian H. Stock Option (right to buy)
Jun 13, 2022 Buy 35 000 Blaustein Marc Common Stock
Jun 13, 2022 Buy 44 843 Hamood Samuel A Stock Option (right to buy)
Jun 13, 2022 Buy 35 000 Vittiglio Joseph Common Stock
Jun 13, 2022 Buy 44 843 Ferrante Domenic J Stock Option (right to buy)
Jun 13, 2022 Buy 44 843 Graf Susan E Stock Option (right to buy)
Jun 13, 2022 Buy 44 843 Graf Susan E Stock Option (right to buy)
Jun 13, 2022 Buy 44 843 Viney Joanne L. Stock Option (right to buy)
Jun 13, 2022 Buy 44 843 Viney Joanne L. Stock Option (right to buy)
Jun 13, 2022 Buy 44 843 Smisek Jeffery A Stock Option (right to buy)
Jun 13, 2022 Buy 44 843 Smisek Jeffery A Stock Option (right to buy)
Jun 13, 2022 Buy 44 843 Haft Nicholas Stock Option (right to buy)
Feb 25, 2022 Buy 38 000 Blaustein Marc Employee Stock Option (right to buy)
Feb 25, 2022 Buy 80 000 Perry Gregory D Employee Stock Option (right to buy)
Feb 25, 2022 Buy 75 000 Vittiglio Joseph Employee Stock Option (right to buy)
Dec 20, 2021 Buy 63 850 Haft Nicholas Common Stock, $0.001 par value per share
Dec 20, 2021 Buy 125 000 Vittiglio Joseph Employee Stock Option (right to buy)
Oct 01, 2021 Buy 25 543 Hamood Samuel A Stock Option (right to buy)
Oct 01, 2021 Buy 0 Hamood Samuel A
Sep 08, 2021 Buy 150 000 Blaustein Marc Employee Stock Option (right to buy)
Sep 08, 2021 Buy 0 Blaustein Marc
May 12, 2021 Buy 23 419 Viney Joanne L. Stock Option (right to buy)
Apr 23, 2021 Buy 23 419 Graf Susan E Stock Option (right to buy)
Apr 23, 2021 Buy 0 Graf Susan E
Mar 23, 2021 Buy 88 235 Smisek Jeffery A Common Stock
Mar 23, 2021 Buy 272 245 Smisek Jeffery A Common Stock
Mar 23, 2021 Buy 297 178 Smisek Jeffery A Common Stock
Mar 23, 2021 Buy 141 928 Smisek Jeffery A Common Stock
Mar 23, 2021 Buy 894 955 Smisek Jeffery A Common Stock
Mar 23, 2021 Sell 272 245 Smisek Jeffery A Series D Preferred Stock
Mar 23, 2021 Sell 894 955 Smisek Jeffery A Series A Preferred Stock
Mar 23, 2021 Sell 141 928 Smisek Jeffery A Series B Preferred Stock
Mar 23, 2021 Sell 297 178 Smisek Jeffery A Series C Preferred Stock
Mar 23, 2021 Buy 366 093 Haft Nicholas Common Stock
Mar 23, 2021 Buy 1 150 481 Haft Nicholas Common Stock
Mar 23, 2021 Buy 1 064 466 Haft Nicholas Common Stock
Mar 23, 2021 Buy 882 351 Haft Nicholas Common Stock
Mar 23, 2021 Buy 212 893 Haft Nicholas Common Stock
Mar 23, 2021 Buy 172 942 Haft Nicholas Common Stock
Mar 23, 2021 Buy 143 831 Haft Nicholas Common Stock
Mar 23, 2021 Sell 212 893 Haft Nicholas Series C Preferred Stock
Mar 23, 2021 Sell 143 831 Haft Nicholas Series A Preferred Stock
Mar 23, 2021 Sell 1 064 466 Haft Nicholas Series B Preferred Stock
Mar 23, 2021 Sell 1 150 481 Haft Nicholas Series D Preferred Stock
Mar 23, 2021 Buy 102 941 Ferrante Domenic J Common Stock
Mar 23, 2021 Buy 90 378 Ferrante Domenic J Common Stock
Mar 23, 2021 Buy 300 948 Ferrante Domenic J Common Stock
Mar 23, 2021 Buy 141 928 Ferrante Domenic J Common Stock
Mar 23, 2021 Sell 141 928 Ferrante Domenic J Series B Preferred Stock
Mar 23, 2021 Sell 300 948 Ferrante Domenic J Series C Preferred Stock
Mar 23, 2021 Sell 90 378 Ferrante Domenic J Series D Preferred Stock
Mar 23, 2021 Buy 735 294 Crestovo Investor Llc Common Stock
Mar 23, 2021 Buy 11 906 147 Crestovo Investor Llc Common Stock
Mar 23, 2021 Sell 8 672 117 Crestovo Investor Llc Series A Preferred Stock
Mar 23, 2021 Sell 1 064 466 Crestovo Investor Llc Series B Preferred Stock
Mar 23, 2021 Sell 1 172 480 Crestovo Investor Llc Series C Preferred Stock
Mar 23, 2021 Sell 997 084 Crestovo Investor Llc Series D Preferred Stock
Mar 18, 2021 Buy 60 578 Vittiglio Joseph Employee Stock Option (right to buy)
Mar 18, 2021 Buy 34 616 Vittiglio Joseph Employee Stock Option (right to buy)
Mar 18, 2021 Buy 595 402 Smith Mark Burnham Employee Stock Option (right to buy)
Mar 18, 2021 Buy 55 386 Perry Gregory D Employee Stock Option (right to buy)
Mar 18, 2021 Buy 69 232 Kassam Zain Employee Stock Option (right to buy)
Mar 18, 2021 Buy 60 578 Vittiglio Joseph Employee Stock Option (right to buy)
Mar 18, 2021 Buy 13 846 Viney Joanne L. Stock Option (right to buy)
Mar 18, 2021 Buy 0 Lange Christian H.
Mar 18, 2021 Buy 0 Smith Mark Burnham Common Stock
Mar 18, 2021 Buy 141 928 Smisek Jeffery A Series B Preferred Stock
Mar 18, 2021 Buy 894 955 Smisek Jeffery A Series A Preferred Stock
Mar 18, 2021 Buy 297 178 Smisek Jeffery A Series C Preferred Stock
Mar 18, 2021 Buy 272 245 Smisek Jeffery A Series D Preferred Stock
Mar 18, 2021 Buy 304 254 Perry Gregory D Employee Stock Option (right to buy)
Mar 18, 2021 Buy 0 Kassam Zain Common Stock
Mar 18, 2021 Buy 8 672 117 Crestovo Investor Llc Series A Preferred Stock
Mar 18, 2021 Buy 1 064 466 Crestovo Investor Llc Series B Preferred Stock
Mar 18, 2021 Buy 1 172 480 Crestovo Investor Llc Series C Preferred Stock
Mar 18, 2021 Buy 997 084 Crestovo Investor Llc Series D Preferred Stock
Mar 18, 2021 Buy 143 831 Haft Nicholas Series A Preferred Stock
Mar 18, 2021 Buy 1 064 466 Haft Nicholas Series B Preferred Stock
Mar 18, 2021 Buy 212 893 Haft Nicholas Series C Preferred Stock
Mar 18, 2021 Buy 1 150 481 Haft Nicholas Series D Preferred Stock
Mar 18, 2021 Buy 141 928 Ferrante Domenic J Series B Preferred Stock
Mar 18, 2021 Buy 300 948 Ferrante Domenic J Series C Preferred Stock
JSON CSV
INSIDER POWER
94.806
Last 100 transactions
Buy: 39 844 438 | Sell: 16 638 981 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 94.806.

In total, the insiders bought 39 844 438 and sold 16 638 981 FNCH shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Finch Therapeutics Group, Inc.

Finch Therapeutics Group. Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides difficile infection, as well as for the treatment of chronic hepatitis B virus. It is also developing FIN-21... FNCH Profile

Golden Star

Ticker Date Change Price
DOOR Apr 17 0.0305% $131.35
LNG Apr 17 3.29% $156.81
FCN Apr 16 1.75% $207.62
ELV Apr 16 4.82% $506.97
FTSL Apr 16 0.217% $46.08
AKR Apr 05 3.15% $16.53
ITCI Apr 05 5.74% $68.44
SARK Mar 28 18.79% $26.88
SON Mar 26 0.83% $56.64
ARCC Mar 25 2.34% $20.12
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT